Shanti Dorfman

Shanti Dorfman is a highly experienced clinical trial manager with a robust background in the biopharmaceutical industry. Currently serving as a Senior Clinical Trial Manager at Tourmaline Bio since January 2024, Shanti previously held the position of Global Study Manager at Genentech from June 2020 to January 2024. Prior to that, Shanti worked at Gilead Sciences as a Senior Clinical Trial Management Associate from November 2015 to October 2019 and as a Senior Clinical Research Associate at MyoScience from June 2013 to October 2015, focusing on clinical trials involving Focused Cold Therapy for peripheral nerve pain. Shanti's career commenced in clinical marketing at AccessClosure, Inc. from March 2004 to February 2009. Shanti holds a Bachelor of Arts degree in English from Mills College.